These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
105 related articles for article (PubMed ID: 19142116)
21. A clinical paradigm of delusions of parasitosis. Sandoz A; LoPiccolo M; Kusnir D; Tausk FA J Am Acad Dermatol; 2008 Oct; 59(4):698-704. PubMed ID: 18793939 [No Abstract] [Full Text] [Related]
22. Is olanzapine a brain-sparing medication? Joober R; Schmitz N; Malla A; Sengupta S; Karma S Arch Gen Psychiatry; 2006 Nov; 63(11):1292. PubMed ID: 17088510 [No Abstract] [Full Text] [Related]
23. Prolongation of clozapine-induced leukopenia with olanzapine treatment. Sayin A; Cosar B Prog Neuropsychopharmacol Biol Psychiatry; 2006 Jul; 30(5):958-9. PubMed ID: 16631295 [TBL] [Abstract][Full Text] [Related]
24. Effects of olanzapine on slow wave sleep, sleep spindles and sleep-related memory consolidation in schizophrenia. Göder R; Fritzer G; Gottwald B; Lippmann B; Seeck-Hirschner M; Serafin I; Aldenhoff JB Pharmacopsychiatry; 2008 May; 41(3):92-9. PubMed ID: 18484550 [TBL] [Abstract][Full Text] [Related]
25. Three case reports of modafinil use in treating sedation induced by antipsychotic medications. Makela EH; Miller K; Cutlip WD J Clin Psychiatry; 2003 Apr; 64(4):485-6. PubMed ID: 12716260 [No Abstract] [Full Text] [Related]
26. Four cases of venous thromboembolism associated with olanzapine. Maly R; Masopust J; Hosak L; Urban A Psychiatry Clin Neurosci; 2009 Feb; 63(1):116-8. PubMed ID: 19067990 [TBL] [Abstract][Full Text] [Related]
27. Predictors of antipsychotic-induced weight gain in first-episode psychosis: conclusions from a randomized, double-blind, controlled prospective study of olanzapine, risperidone, and haloperidol. Saddichha S; Ameen S; Akhtar S J Clin Psychopharmacol; 2008 Feb; 28(1):27-31. PubMed ID: 18204337 [TBL] [Abstract][Full Text] [Related]
36. Reversible delayed onset olanzapine-associated leukopenia and neutropenia in a clozapine-naive patient on concomitant depot antipsychotic. Thinn SS; Liew E; May AL; Chua HC; Sim K J Clin Psychopharmacol; 2007 Aug; 27(4):394-5. PubMed ID: 17632225 [No Abstract] [Full Text] [Related]
37. Olanzapine-induced neuroleptic malignant syndrome in a patient with paranoid schizophrenia. Srivastava A; Borkar HA; Chandak S Psychiatry Clin Neurosci; 2009 Feb; 63(1):119-21. PubMed ID: 19067992 [TBL] [Abstract][Full Text] [Related]
38. Methodological concerns in a trial of ziprasidone and olanzapine. Ross DE Am J Psychiatry; 2005 Jul; 162(7):1391; author reply 1391-2. PubMed ID: 15994735 [No Abstract] [Full Text] [Related]
39. Long-term antipsychotic monotherapy for schizophrenia: disease burden and comparative outcomes for patients treated with olanzapine, quetiapine, risperidone, or haloperidol monotherapy in a pan-continental observational study. Dossenbach M; Pecenak J; Szulc A; Irimia V; Anders M; Logozar-Perkovic D; Peciukaitiene D; Kotler M; Smulevich AB; West TM; Lowry AJ; Treuer T J Clin Psychiatry; 2008 Dec; 69(12):1901-15. PubMed ID: 19012820 [TBL] [Abstract][Full Text] [Related]
40. [Mortality and cumulative exposure to antipsychotics, antidepressants and benzodiazepines in patients with schizophrenia: an observational follow-up study]. Tiihonenl J; Mittendorfer-Rutz E; Torniainen M; Alexanderson K; Tanskanen A Duodecim; 2016; 132(2):181. PubMed ID: 26939492 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]